Examining US commercial health plans’ use of The Institute for Clinical and Economic Review’s reports in specialty drug coverage decisions

The Institute for Clinical and Economic Review (ICER) has a prominent role in US health care. We found an association between ICER’s value assessments and how US commercial health plans cover specialty drugs. We also found that although health plans rarely cite ICER’s assessments, they are doing so...

Full description

Saved in:
Bibliographic Details
Published in:Journal of managed care & specialty pharmacy 2023-03, Vol.29 (3), p.257-264
Main Authors: Chambers, James D, Enright, Daniel E, Panzer, Ari D, Cohen, Josh T, Ollendorf, Daniel A, Neumann, Peter J
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Institute for Clinical and Economic Review (ICER) has a prominent role in US health care. We found an association between ICER’s value assessments and how US commercial health plans cover specialty drugs. We also found that although health plans rarely cite ICER’s assessments, they are doing so more frequently.
ISSN:2376-0540
2376-1032
DOI:10.18553/jmcp.2023.29.3.257